CPSC
PRAX icon

Carl P. Sherr & Co’s Praxis Precision Medicines PRAX Stock Holding History

Carl P. Sherr & Co’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$313K Buy
972
+75
+8% +$23.2K 0.15% 103
2025
Q4 		$282K Buy
+897
New +$167K 0.13% 111

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Carl P. Sherr & Co's PRAX Position: Q1 2026 in Review

Carl P. Sherr & Co increased its Praxis Precision Medicines (PRAX) stake by 8.4% in Q1 2026, buying an estimated $23.2K and bringing the position to 972 shares worth $313K. The position accounts for 0.15% of the portfolio, ranked #103.

Carl P. Sherr & Co first reported a position in PRAX in Q4 2025 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Carl P. Sherr & Co held 972 shares of Praxis Precision Medicines worth $313K as of Q1 2026.
  • Carl P. Sherr & Co bought 75 Praxis Precision Medicines shares in Q1 2026, an estimated $23.2K.
  • Praxis Precision Medicines made up 0.15% of Carl P. Sherr & Co's portfolio in Q1 2026, its #103 holding.
  • Carl P. Sherr & Co first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Carl P. Sherr & Co's 13F filing for Q1 2026, filed 7 May 2026.